Erratum: Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling (Clinical Science (2015) 129:4 (331–344) DOI: 10.1042/CS20140789);Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling

Clinical Science

Volumn 129, Issue 4, 2015, Pages 331-344

  Liu, Yanan ^a   Jin, Jiqin ^a   Qiao, Shigang ^a   Lei, Shaoqing ^a,b   Liao, Songyan ^a   Ge, Zhi Dong ^c   Li, Haobo ^a   Wong, Gordon Tin chun ^a   Irwin, Michael G ^a   Xia, Zhengyuan ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Caveolin 3; Diabetes; Myocardial ischaemia reperfusion injury; Protein kinase C

Indexed keywords

CAVEOLIN 3; CGP 53353; GLUCOSE; PROTEIN KINASE B; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 2; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; SMALL INTERFERING RNA; STREPTOZOCIN; UNCLASSIFIED DRUG; 15-F2T-ISOPROSTANE; 4,5-DIANILINOPHTHALIMIDE; CAV3 PROTEIN, RAT; INDOLE DERIVATIVE; ISOPROSTANE DERIVATIVE; MALEIMIDE DERIVATIVE; PHTHALIMIDE DERIVATIVE; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; DIABETES MELLITUS; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HYPOXIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TUNEL ASSAY; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; APOPTOSIS; CAVEOLIN 3; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; ENZYME ACTIVATION; INDOLES; ISOPROSTANES; MALE; MALEIMIDES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHORYLATION; PHTHALIMIDES; PROTEIN KINASE C BETA; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VENTRICULAR FUNCTION, LEFT;

EID: 84938513239     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS-2014-0789_COR     Document Type: Erratum

References (43)

1. Nesto, R.W. and Zarich, S. (1998) Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition. Circulation 97, 12-15.
2. Jacoby, R.M. and Nesto, R.W. (1992) Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J. Am. Coll. Cardiol. 20, 736-744.
3. Partamian, J.O. and Bradley, R.F. (1965) Acute myocardial infarction in 258 cases of diabetes: immediate mortality and five-year survival. N. Engl. J. Med. 273, 455-461.
4. Ishihara, M., Inoue, I., Kawagoe, T., Shimatani, Y., Kurisu, S., Nishioka, K., Kouno, Y., Umemura, T., Nakamura, S. and Sato, H. (2001) Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J. Am. Coll. Cardiol. 38, 1007-1011.
5. Zuanetti, G., Latini, R., Maggioni, A.P., Franzosi, M., Santoro, L. and Tognoni, G. (1997) Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation 96, 4239-4245.
6. Woodfield, S.L., Lundergan, C.F., Reiner, J.S., Greenhouse, S.W., Thompson, M.A., Rohrbeck, S.C., Deychak, Y., Simoons, M.L., Califf, R.M., Topol, E.J. and Ross, A.M. (1996) Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J. Am. Coll. Cardiol. 28, 1661-1669.
7. Naruse, K., Rask-Madsen, C., Takahara, N., Ha, S.W., Suzuma, K., Way, K.J., Jacobs, J.R., Clermont, A.C., Ueki, K., Ohshiro, Y. et al. (2006) Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 55, 691-698.
8. Lei, S., Li, H., Xu, J., Liu, Y., Gao, X., Wang, J., Ng, K.F., Lau, W.B., Ma, X.L., Rodrigues, B. et al. (2013) Hyperglycemia-induced protein kinase Cβ2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling. Diabetes 62, 2318-2328.
9. Li, H., Liu, Z., Wang, J., Wong, G.T., Cheung, C.W., Zhang, L., Chen, C., Xia, Z. and Irwin, M.G. (2013) Susceptibility to myocardial ischemia reperfusion injury at early stage of type 1 diabetes in rats. Cardiovasc. Diabetol. 12, 133.
10. Kouroedov, A., Eto, M., Joch, H., Volpe, M., Luscher, T.F. and Cosentino, F. (2004) Selective inhibition of protein kinase Cβ2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 110, 91-96.
11. Chen, Z., Wang, G., Zhai, X., Hu, Y., Gao, D., Ma, L., Yao, J. and Tian, X. (2014) Selective inhibition of protein kinase Cβ2 attenuates the adaptor P66 Shc-mediated intestinal ischemia-reperfusion injury. Cell Death Dis. 5, e1164.
12. Kong, L., Andrassy, M., Chang, J.S., Huang, C., Asai, T., Szabolcs, M.J., Homma, S., Liu, R., Zou, Y.S., Leitges, M. et al. (2008) PKCβ modulates ischemia-reperfusion injury in the heart. Am. J. Physiol. Heart Circ. Physiol. 294, H1862-H1870.
13. Fujita, T., Asai, T., Andrassy, M., Stern, D.M., Pinsky, D.J., Zou, Y.S., Okada, M., Naka, Y., Schmidt, A.M. and Yan, S.F. (2004) PKCβ regulates ischemia/reperfusion injury in the lung. J. Clin. Invest. 113, 1615-1623.
14. Liu, Y., Lei, S., Gao, X., Mao, X., Wang, T., Wong, G.T., Vanhoutte, P.M., Irwin, M.G. and Xia, Z. (2012) PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Clin. Sci. 122, 161-173.
15. See Hoe, L.E., Schilling, J.M., Tarbit, E., Kiessling, C.J., Busija, A.R., Niesman, I.R., Du Toit, E., Ashton, K.J., Roth, D.M., Headrick, J.P. et al. (2014) Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 307, H895-H903.
16. Zhao, J., Wang, F., Zhang, Y., Jiao, L., Lau, W.B., Wang, L., Liu, B., Gao, E., Koch, W.J., Ma, X.L. and Wang, Y. (2013) Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition. Circulation 128 (Suppl. 1), S121-S129.
17. Horikawa, Y.T., Patel, H.H., Tsutsumi, Y.M., Jennings, M.M., Kidd, M.W., Hagiwara, Y., Ishikawa, Y., Insel, P.A. and Roth, D.M. (2008) Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 44, 123-130.
18. Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R.N. and Walsh, K. (2000) Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101, 660-667.
19. Tong, H.Y., Imahashi, K., Steenbergen, C. and Murphy, E. (2002) Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinasedependent pathway is cardioprotective. Circ. Res. 90, 377-379.
20. Xu, J., Li, H., Irwin, M.G., Xia, Z.Y., Mao, X., Lei, S., Wong, G.T., Hung, V., Cheung, C.W., Fang, X. et al. (2014) Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats. Crit. Care Med. 42, e583-e594.
21. Tomlinson, K.C., Gardiner, S.M., Hebden, R.A. and Bennett, T. (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol. Rev. 44, 103-150.
22. Wang, T., Mao, X., Li, H., Qiao, S., Xu, A., Wang, J., Lei, S., Liu, Z., Ng, K.F., Wong, G.T. et al. (2013) N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Radic. Biol. Med. 63, 291-303.
23. Cracowski, J.L., Durand, T. and Bessard, G. (2002) Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol. Sci. 23, 360-366.
24. Wang, T., Qiao, S., Lei, S., Liu, Y., Ng, K.F., Xu, A., Lam, K.S., Irwin, M.G. and Xia, Z. (2011) N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats. PLoS ONE 6, e23967.
25. Gao, X., Zhang, H., Zhuang, W., Yuan, G., Sun, T., Jiang, X., Zhou, Z., Yuan, H., Zhang, Z. and Dong, H. (2014) PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect. Sci. Rep. 4, 5637.
26. St John Sutton, M., Lee, D., Rouleau, J.L., Goldman, S., Plappert, T., Braunwald, E. and Pfeffer, M.A. (2003) Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 107, 2577-2582.
27. Sutton, M.G. and Sharpe, N. (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101, 2981-2988.
28. Monassier, J.P. (2008) Reperfusion injury in acute myocardial infarction; from bench to cath lab. Part I: basic considerations. Arch. Cardiovasc. Dis. 101, 491-500.
29. Joy, S.V., Scates, A.C., Bearelly, S., Dar, M., Taulien, C.A., Goebel, J.A. and Cooney, M.J. (2005) Ruboxistaurin, a protein kinase Cβ inhibitor, as an emerging treatment for diabetes microvascular complications. Ann. Pharmacother. 39, 1693-1699.
30. Casellini, C.M., Barlow, P.M., Rice, A.L., Casey, M., Simmons, K., Pittenger, G., Bastyr, 3rd, E.J., Wolka, A.M. and Vinik, A.I. (2007) A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-β inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 30, 896-902.
31. Vinik, A. (2005) The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications. Expert Opin. Investig. Drugs 14, 1547-1559.
32. Wei, L., Sun, D., Yin, Z., Yuan, Y., Hwang, A., Zhang, Y., Si, R., Zhang, R., Guo, W., Cao, F. and Wang, H. (2010) A PKC-β inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats. Apoptosis 15, 488-498.
33. Kong, L., Andrassy, M., Chang, J.S., Huang, C., Asai, T., Szabolcs, M.J., Homma, S., Liu, R., Zou, Y.S., Leitges, M. et al. (2008) PKCβ modulates ischemia-reperfusion injury in the heart. Am. J. Physiol. Heart Circ. Res. 294, H1862-H1870.
34. shc-mediated mitochondrial apoptotic pathway. Apoptosis 19, 1342-1353.
35. van Empel, V.P., Bertrand, A.T., Hofstra, L., Crijns, H.J., Doevendans, P.A. and De Windt, L.J. (2005) Myocyte apoptosis in heart failure. Cardiovasc. Res. 67, 21-29.
36. Song, F., Shan, Y., Cappello, F., Rappa, F., Ristagno, G., Yu, T., Li Volti, G., Sun, S., Weil, M.H. and Tang, W. (2010) Apoptosis is not involved in the mechanism of myocardial dysfunction after resuscitation in a rat model of cardiac arrest and cardiopulmonary resuscitation. Crit. Care Med. 38, 1329-1334.
37. Eefting, F., Rensing, B., Wigman, J., Pannekoek, W.J., Liu, W.M., Cramer, M.J., Lips, D.J. and Doevendans, P.A. (2004) Role of apoptosis in reperfusion injury. Cardiovasc. Res. 61, 414-426.
38. Calvert, J.W., Gundewar, S., Jha, S., Greer, J.J., Bestermann, W.H., Tian, R. and Lefer, D.J. (2008) Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 57, 696-705.
39. + and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276, 2571-2575.
40. Weiss, J.N., Korge, P., Honda, H.M. and Ping, P. (2003) Role of the mitochondrial permeability transition in myocardial disease. Circ. Res. 93, 292-301.
41. 2+ cycling and mitochondrial permeability transition pores promotes reperfusion-induced injury of cardiac myocytes. J. Cell. Mol. Med. 15, 2478-2485.
42. Tompkins, A.J., Burwell, L.S., Digerness, S.B., Zaragoza, C., Holman, W.L. and Brookes, P.S. (2006) Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim. Biophys. Acta 1762, 223-231.
43. Liu, Y., Jin, J., Li, H., Huang, H., Irwin, M.G. and Xia, Z. (2014) Inhibition of PKC β2 attenuates myocardial ischemia reperfusion injury in diabetic rat through caveolin-3-dependent Akt activation. Circulation 130, A18247.